Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
Psoriasis is a chronic inflammatory disease characterized by erythematous scaly plaques, accompanied by systemic damage that leads to the development of multiple comorbidities. In particular, the association between psoriasis and cardiometabolic comorbidities, including cardiovascular diseases (CVDs...
Saved in:
Main Authors: | Jiangluyi Cai, Lian Cui, Yu Wang, Ying Li, Xilin Zhang, Yuling Shi |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/29eef2a332c8487a99e5fcd26e4944c8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Behavioral Risk Factors and Cardiometabolic Comorbidities of Psoriatic Arthritis and Psoriasis: A Case–Control Study in Chinese Patients
by: Wang Q, et al.
Published: (2021) -
Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
by: Teklu M, et al.
Published: (2021) -
Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
by: Landriscina A, et al.
Published: (2016) -
Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
by: Aalemi AK, et al.
Published: (2021) -
Psoriasis
by: MOLL LEE,NORMAN
Published: (1947)